Drug Trial Radar · NCT06643728
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
252
Actual
Start
Oct 21, 2024
Primary completion
Jan 16, 2026
Study completion Oct 27, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Oct 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy and safety of Bimagrumab and Tirzepatide, alone or in combination, in adults with obesity or overweight, with at least one obesity related comorbidity, without Type 2 Diabetes. The study will last about 70 weeks.
Conditions
- Obesity
- Overweight
Interventions
BimagrumabDrug
Administered SC
TirzepatideDrug
Administered SC
Bimagrumab PlaceboDrug
Administered SC
Tirzepatide PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Body WeightTime frame: Baseline, Week 24
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama
Central Research Associates
Birmingham, Alabama
Diablo Clinical Research, Inc.
Walnut Creek, California
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare
Jacksonville, Florida
Altus Research
Lake Worth, Florida
Suncoast Research Group
Miami, Florida
East-West Medical Research Institute
Honolulu, Hawaii
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois
SKY Integrative Medical Center/SKYCRNG
Ridgeland, Mississippi
Keystone Clinical Studies
Plymouth Meeting, Pennsylvania
Eastside Research Associates
Redmond, Washington
Rainier Clinical Research Center
Renton, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.